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TetracyanoquinodimethaneAbstract Two simple, rapid and sensitive spectrophotometric methods for the determination of
amlodipine besylate (ADB) in pure form and in pharmaceutical preparations have been developed.
The methods are based on the charge transfer reactions between the drug as electron donor with
7,7,8,8-tetracyanoquinodimethane (TCNQ) and tetracyanoethylene (TCNE) as p-acceptors in order
to the formation of charge transfer (CT) complexes. These reactions give colored products which
have maximum absorption bands at 745 and 396 nm for TCNQ and TCNE, respectively. Beer’s
law is obeyed in the concentration ranges 20–110 lg mL1 and 5–35 lg mL1 for ADB using
TCNQ and TCNE reagents. The molar absorptivities are 2.73 · 103 and 6.43 · 103 L mol1 cm
and the Sandell (S) sensitivities are 0.14 lg cm2 and 0.063 lg cm2 using TCNQ and TCNE
reagents, respectively, which indicate the high sensitivity of the proposed methods. The relative
standard deviations (R.S.D.: 0.94 and 0.73) obtained using TCNQ and TCNE reagents, respec-
tively, refer to the high accuracy and precision of the proposed method.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.1. Introduction
Amlodipine besylate (ADB) is 2-[(2-aminoethoxy)-methyl]-4-
2-chlorophenyl), 1,4-dihydro-6-methyl-3,5-pyridine dicarbox-
ylic acid, and 3-ethyl-5-methyl ester. ADB, a calcium channel
blocker with vasodilatory activity similar to those of nifedi-
pine, is mainly used in antianginal, antihypertensive and anti-
arrhythmic activities.1
Different analytical methods that have been reported for
the determination of amlodipine including, high-performance
liquid chromatography,2–7 gas chromatography coupled with
mass spectrometry,8 high-performance thin layer liquid
110 N. Alizadeh, F. Hematichromatography,9,10 and ﬂuorimetry.11 A number of other
extractive spectrophotometric methods,12–16 have been also re-
ported. Moreover amlodipine besylate in pharmaceutical prep-
arations was determined using the formation of Charge
transfer complexes based on the reaction of ADB with an elec-
tron acceptor named DDQ.17
Charge transfer phenomena were introduced by Mulliken
and widely discussed by Foster to deﬁne a new type of adducts.
Molecular interactions between electron donors and acceptors
are generally the formation of intensely colored charge transfer
complexes which have absorbance in visible region.18 Charge
transfer interactions within the formation of molecular com-
plex involving a resonance with a transfer of charge from an
electron donor (D) to an electron acceptor (A) were also
showed by Mulliken.19,20
DþA$ Dþ þA ð1Þ
Many drugs are easy to determine by spectrophotometry
based on color charge transfer (CT) complexes formed be-
tween electron acceptors, either p- or d-acceptors and drugs
as electron donors either n or p donors. This paper reports
simple, direct, sensitive and precise spectrophotometric meth-
ods for the determination of amlodipine via complexation with
two p-acceptors, tetracyanoethylene (TCNE) and 7,7,8,8-tetra-
cyanoquinodimethane (TCNQ) which are known to yield
charge transfer complexes with a variety of electron donors21
and to use these reagents for the quantitative determination
of the drug in its dosage forms.
2. Materials and methods
2.1. Instrumentation
All the absorption spectral measurements were made using a
RAYLEIGHUV-1800 UV–Vis spectrophotometer (china)
with Wavelength Range 190–1100 nm and Spectral Bandwidth
of 2 nm equipped with quartz cells.
2.2. Chemicals and reagents
The reagents used were of analytical grade and solvents used
were of spectroscopic grade. Pure ADB was obtained from
commercial source (Sobhan Company, Rasht, Iran). FreshFigure 1 (a) Absorption spectra of the reaction products of ADB wit
with TCNE.solutions of TCNQ (Merck) or TCNE (Merck) (0.02% w/v)
in acetonitrile (Merck) were prepared.
2.3. Standard solutions
Stock solution of pure ADB (1 mg mL1) was prepared by dis-
solving of 100 mg of ADB in 100 mL acetonitrile. The working
standard solution (100 lg mL1) was prepared by stepwise
dilutions of the stock solution with acetonitrile.
2.4. Procedures
2.4.1. Construction of calibration curve
Aliquots containing from 5 to 35 lg mL1 of pure ADB for
the TCNE method and 20–110 lg mL1 for the TCNQ meth-
od were transferred into a series of 5 mL volumetric ﬂasks.
1.0 mL of 0.02% TCNQ or TCNE solution was added to them
and the solutions were diluted to volume with acetonitrile. The
solutions were left to stand for 70 and 30 min at room temper-
ature, afterward the absorbance of the standard solutions was
measured at k= 745 and 396 nm for TCNQ and TCNE meth-
ods, respectively. These measurements were performed against
the reagent blank prepared simultaneously.
2.4.2. Procedure for dosage forms
Twenty tablets of ADB were weighed and powdered. The pow-
der equivalent to 10 mg of ADB was weighed accurately, dis-
solved in least amount of acetonitrile, ﬁltered through
Whatmann ﬁlter paper No. 42 and washed with the acetoni-
trile solvent. Then, washing solution was diluted to 100 mL
with acetonitrile in a 100 mL calibrated ﬂask. The procedure
was continued as described under general procedures.3. Results and discussion
3.1. Spectral characteristics
When the solution of ADB (Lewis base) was mixed with the
solution of p-acceptors (Lewis acid) in acetonitrile at room
temperature, an intense green product was produced for the
TCNQ method which had maximum absorption band at
k= 745 nm as shown in Fig. 1a and an intense yellow producth TCNQ. (b) Absorption spectra of the reaction products of ADB
Figure 2 (a) Effect of time on the formation of colored product
with ADB (50 lg mL1) and TCNQ (0.02% w/v). (b) Effect of
time on the formation of colored product with ADB (30 lg mL1)
and TCNE (0.02% w/v).
Figure 3 (a) Effect of mL reagent for the TCNQ method (ADB
used in concentration of 50 lg mL1). (b) Effect of mL reagent for
TCNE (ADB used in concentration of 30 lg mL1).
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Scheme 1 (a) Structure of ADB–TCNE complex and (b)
structure of ADB–TCNQ complex.
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Figure 4 (a) Stoichiometry measurement through the molar
ratio method for the TCNQ method (ADB and TCNQ used in the
concentration of 103 M). (b) Stoichiometry measurement for the
TCNE method (ADB and TCNE used in the concentration of
103 M). VR refers to volume of reagent.
Determination of amlodipine besylate 111which exhibits a maximum absorption band at k= 396 nm
(Fig. 1b). The CT complexes were formed by the interaction
of the investigated drugs as n-electron donor and TCNQ and
TCNE reagents as p-acceptors.
3.2. Method optimization
In order to optimize the conditions, we have investigated a
number of parameters such as volume of reagents, nature of
solvent and reaction time.
3.2.1. Effect of solvent
Different solvents were investigated in order to select the suit-
able solvent for TCNQ and TCNE methods. These solvents in-
cluded acetonitrile, chloroform and methanol. It is found that
acetonitrile is considered to be an ideal solvent for this exper-
iment because it has a suitable solvating power for TCNE and
TCNQ as well as producing more stable and reproducible
absorbance. Due to the mentioned reasons we decided to com-
plete our work with acetonitrile.
3.2.2. Effect of time
Optimization of reaction time was carried out by measuring
the absorbance of the CT complexes at different time intervals
at room temperature (25 C) for both the reagents. Complete
color development was attained either instantaneously or after70 and 30 min for TCNQ and TCNE reagents, respectively
(Fig. 2).
3.2.3. Effect of reagents volumes
Various volumes of TCNQ and TCNE reagents added to ﬁxed
concentrations of ADB in acetonitrile and the results are
Figure 5 (a) Calibration curve for the TCNE method. (b) Calibration curve for the TCNQ method.
Table 1 Spectrophotometric parameters of determination.
Parameter TCNQ TCNE
kmax (nm) 745 396
Beer’s law limits (lg/mL) 20–110 5–35
e (L mol1 cm1) 2.73 · 103 6.43 · 103
Regression equation Y= 0.0081X  0.0679 Y= 0.0098X+ 0.0804
Correlation coeﬃcient (r) 0.9996 0.9993
Relative standard deviation (% RSD) 0.94 0.73
Limit of detection (lg mL1) 0.75 0.60
Limit of quantiﬁcation (lg mL1) 2.50 2.00
Sandell sensitivity (lg cm1) 0.14 0.063
112 N. Alizadeh, F. Hematishown in Fig. 3. We found that 1 mL of 0.02% (w/v) TCNQ
and TCNE is the optimized volume for the formation of CT
complexes in order to cause maximum and reproducible color
intensity.
3.3. Mechanism of reaction between ADB with TCNQ and
TCNE
A p–p*charge transfer complex is formed by the transfer of
electron from the benzene ring (electron rich group) of the
ADB as electron donor to the electron-acceptor reagents
(TCNE and TCNQ).22,23 The structures of the complexes
formed between the drug and reagents (TCNE and TCNQ)
are shown in Scheme 1a and b.Table 2 Spectrophotometric microdetermination of ADB in differen
TCNE by the proposed and reference method.24
Pharmaceutical
preparations
Conc. taken
(lg mL1)
Conc. found
(lg mL1)
Amlodipine 30.00 30.125
Amlopres 30.00 29.875
Pharmaceutical preparations Conc. taken (lg mL1) Conc. found (lg
Amlodipine 80.00 79.20
Amlopres 80.00 79.63
In the HPLC method reference parameters are as follows: C18 column
potassium dihydrogen orthophosphate buffer:methanol (15:30:55) and pH
a Average of three independent analyses.3.4. Stoichiometry of the CT complexes
The molar ratio method is applied in order to determine the
suitable ratio between ADB and TCNQ or TCNE reagents.
The results show that 1:1 complexes were formed between
the drug and TCNQ, TCNE reagents as shown in Fig. 4.3.5. Method validation
3.5.1. Linearity and range
After the optimization of different parameters such as solvents,
time and reagent volumes, the calibration curves can be con-
structed by plotting absorbances versus concentrations (Fig. 5).t pharmaceutical preparations via their reaction with TCNQ and
TCNE method Reference method
Recoverya
(%)
RSDa
(%)
Recoverya
(%)
RSDa
(%)
100.40 0.57 100.13 0.73
99.50 0.58 99.98 0.51
mL1) TCNQ method Reference method
RSDa (%) Recoverya (%) RSDa (%) Recoverya (%)
0.29 99.00 0.73 100.13
0.57 99.60 0.51 99.98
250 mm · 4.6 mm (5 lm), with acetonitrile as mobile phase:70 mM
adjusted to 3.0.
Table 3 Standard addition determination of amlodipine in dosage forms.
Formulation name Labeled amount (mg) TCNQ method TCNE method
Found (mg) Recovery (%) R.S.Da (%) Found (mg) Recovery (%) R.S.Da (%)
Amlodipine 10.00 10.08 100.8 0.61 9.8 98.00 0.52
Amlopres 10.00 9.91 99.1 0.73 10.6 100.6 0.65
a Average of three determinations.
Determination of amlodipine besylate 113Beer’s law is obeyed over the concentration ranges 20–
110 lg mL1 for TCNQ and 5–35 lg mL1 for TCNE. Table 1
shows the different analytical parameters obtained such as
regression equation, molar absorptivity and Sandell sensitivity.
The small value of Sandell sensitivity and the high value of mo-
lar absorptivity (e) indicate the high sensitivity of the proposed
method for the determination of ADB.
3.6. Application of the proposed method
The proposed methods were successfully applied for the deter-
mination of ADB in tablet forms and the results are given in
Table 2. Recovery studies were applied in order to investigate
the reproducibility of the methods. The precision is expressed
as the Relative Standard Deviation (R.S.D) and the data were
found with three independent analysis using calibration curves.
Table 2 demonstrates the low value of R.S.D as well as suitable
recovery percentages which are close to 100%. The compari-
son of recovery percentages and R.S.D values of the proposed
method and reference method24 indicate good accuracy and
precision of the proposed methods.
In addition for further investigation the amount of ADB in
tablet form was obtained by the standard addition method.
Table 3 demonstrates the results of standard addition determi-
nation of ADB. In the standard addition method the concen-
tration of an unknown solution is obtained by adding
different volumes of standard solution and constructing the
concerned graph. Table 3 also shows that recovery percentages
are close to 100% too and ranged from 99.10 to 100.80 which
indicate the high efﬁciency of the proposed methods.
4. Conclusions
The data given above reveal that the proposed methods are
simple, rapid, accurate, precise and economical. With these
methods, one can do the analysis with pace at low cost without
losing accuracy. The proposed methods may be applied for
routine analysis as well as quantitative determination of the
ADB in quality control laboratories in pharmaceutical
formulations.
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